Loading…
Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors
α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiologica...
Saved in:
Published in: | Molecular pharmacology 2015-12, Vol.88 (6), p.993-1001 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383 |
---|---|
cites | cdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383 |
container_end_page | 1001 |
container_issue | 6 |
container_start_page | 993 |
container_title | Molecular pharmacology |
container_volume | 88 |
creator | Kompella, Shiva N. Cuny, Hartmut Hung, Andrew Adams, David J. |
description | α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction. |
doi_str_mv | 10.1124/mol.115.100503 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_mol_115_100503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026895X24032103</els_id><sourcerecordid>26438212</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</originalsourceid><addsrcrecordid>eNp1kE1OIzEQRi0EgsDMliXyBTq43Ha6exkCM4nEj5SZkWbXctxlMOrYke1EZMWZuAhnwijAjkWpavG9T6VHyCmwIQAX50vf50MOgTHJyj0yAMmhYACwTwaM8VFRN_L_ETmO8ZExELJmh-SIj0RZc-AD8nzje9TrXgV6oaKN1PhAL60xGNAlq3r6B120yW5s2lJv6OtLMfHOJ_9kHZ3j_Ww2pirReR7lOjpdL5Wjt7gO3mX41mqfrLOajjWmba8ffG8dZlDjKvkQf5ADo_qIPz_2Cfn36-rvZFpc3_2eTcbXhS5rkQohQZULiZUSleFc8lFtmqZSjTCi7hgsQKJSldAda0YKJXYVGGMUMg5KlnV5Qoa7Xh18jAFNuwp2qcK2Bda-m2yzyXzIdmcyA2c7YLVeLLH7in-qy4F6F8D89sZiaKO26DR2NqBObeftd91vMGeEfw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</title><source>Full-Text Journals in Chemistry (Open access)</source><creator>Kompella, Shiva N. ; Cuny, Hartmut ; Hung, Andrew ; Adams, David J.</creator><creatorcontrib>Kompella, Shiva N. ; Cuny, Hartmut ; Hung, Andrew ; Adams, David J.</creatorcontrib><description>α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.115.100503</identifier><identifier>PMID: 26438212</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Conotoxins - chemistry ; Conotoxins - metabolism ; Dose-Response Relationship, Drug ; Female ; Humans ; Nicotinic Antagonists - chemistry ; Nicotinic Antagonists - metabolism ; Protein Structure, Secondary ; Rats ; Receptors, Nicotinic - chemistry ; Receptors, Nicotinic - metabolism ; Xenopus laevis</subject><ispartof>Molecular pharmacology, 2015-12, Vol.88 (6), p.993-1001</ispartof><rights>2015 American Society for Pharmacology and Experimental Therapeutics</rights><rights>Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</citedby><cites>FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26438212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kompella, Shiva N.</creatorcontrib><creatorcontrib>Cuny, Hartmut</creatorcontrib><creatorcontrib>Hung, Andrew</creatorcontrib><creatorcontrib>Adams, David J.</creatorcontrib><title>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction.</description><subject>Animals</subject><subject>Conotoxins - chemistry</subject><subject>Conotoxins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Humans</subject><subject>Nicotinic Antagonists - chemistry</subject><subject>Nicotinic Antagonists - metabolism</subject><subject>Protein Structure, Secondary</subject><subject>Rats</subject><subject>Receptors, Nicotinic - chemistry</subject><subject>Receptors, Nicotinic - metabolism</subject><subject>Xenopus laevis</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kE1OIzEQRi0EgsDMliXyBTq43Ha6exkCM4nEj5SZkWbXctxlMOrYke1EZMWZuAhnwijAjkWpavG9T6VHyCmwIQAX50vf50MOgTHJyj0yAMmhYACwTwaM8VFRN_L_ETmO8ZExELJmh-SIj0RZc-AD8nzje9TrXgV6oaKN1PhAL60xGNAlq3r6B120yW5s2lJv6OtLMfHOJ_9kHZ3j_Ww2pirReR7lOjpdL5Wjt7gO3mX41mqfrLOajjWmba8ffG8dZlDjKvkQf5ADo_qIPz_2Cfn36-rvZFpc3_2eTcbXhS5rkQohQZULiZUSleFc8lFtmqZSjTCi7hgsQKJSldAda0YKJXYVGGMUMg5KlnV5Qoa7Xh18jAFNuwp2qcK2Bda-m2yzyXzIdmcyA2c7YLVeLLH7in-qy4F6F8D89sZiaKO26DR2NqBObeftd91vMGeEfw</recordid><startdate>201512</startdate><enddate>201512</enddate><creator>Kompella, Shiva N.</creator><creator>Cuny, Hartmut</creator><creator>Hung, Andrew</creator><creator>Adams, David J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201512</creationdate><title>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</title><author>Kompella, Shiva N. ; Cuny, Hartmut ; Hung, Andrew ; Adams, David J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Conotoxins - chemistry</topic><topic>Conotoxins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Humans</topic><topic>Nicotinic Antagonists - chemistry</topic><topic>Nicotinic Antagonists - metabolism</topic><topic>Protein Structure, Secondary</topic><topic>Rats</topic><topic>Receptors, Nicotinic - chemistry</topic><topic>Receptors, Nicotinic - metabolism</topic><topic>Xenopus laevis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kompella, Shiva N.</creatorcontrib><creatorcontrib>Cuny, Hartmut</creatorcontrib><creatorcontrib>Hung, Andrew</creatorcontrib><creatorcontrib>Adams, David J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kompella, Shiva N.</au><au>Cuny, Hartmut</au><au>Hung, Andrew</au><au>Adams, David J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2015-12</date><risdate>2015</risdate><volume>88</volume><issue>6</issue><spage>993</spage><epage>1001</epage><pages>993-1001</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>α-Conotoxins, as nicotinic acetylcholine receptor (nAChR) antagonists, are powerful tools for dissecting biologic processes and guiding drug development. The α3β2 and α3β4 nAChR subtypes are expressed in the central and peripheral nervous systems and play a critical role in various pathophysiological conditions ranging from nicotine addiction to the development and progression of lung cancer. Here we used the α4/7-conotoxin RegIIA, a disulfide-bonded peptide from the venom of Conus regius, and its analog [N11A,N12A]RegIIA to probe the specific pharmacological properties of rat and human nAChR subtypes. nAChR subtypes were heterologously expressed in Xenopus oocytes and two-electrode voltage clamp recordings used to investigate the effects of the peptides on nAChR activity. RegIIA potently inhibited currents evoked by acetylcholine (ACh) at rat α3β2 (IC50 = 10.7 nM), whereas a 70-fold lower potency was observed at human α3β2 nAChR (IC50 = 704.1 nM). Conversely, there were no species-specific differences in sensitivity to RegIIA at the α3β4 nAChR. Receptor mutagenesis and molecular dynamics studies revealed that this difference can be attributed primarily to a single amino acid change: Glu198 on the rat α3 subunit corresponding to a proline on the human subunit. These findings reveal a novel species- and subunit-specific receptor-antagonist interaction.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26438212</pmid><doi>10.1124/mol.115.100503</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-895X |
ispartof | Molecular pharmacology, 2015-12, Vol.88 (6), p.993-1001 |
issn | 0026-895X 1521-0111 |
language | eng |
recordid | cdi_crossref_primary_10_1124_mol_115_100503 |
source | Full-Text Journals in Chemistry (Open access) |
subjects | Animals Conotoxins - chemistry Conotoxins - metabolism Dose-Response Relationship, Drug Female Humans Nicotinic Antagonists - chemistry Nicotinic Antagonists - metabolism Protein Structure, Secondary Rats Receptors, Nicotinic - chemistry Receptors, Nicotinic - metabolism Xenopus laevis |
title | Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A45%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Basis%20for%20Differential%20Sensitivity%20of%20%CE%B1-Conotoxin%20RegIIA%20at%20Rat%20and%20Human%20Neuronal%20Nicotinic%20Acetylcholine%20Receptors&rft.jtitle=Molecular%20pharmacology&rft.au=Kompella,%20Shiva%20N.&rft.date=2015-12&rft.volume=88&rft.issue=6&rft.spage=993&rft.epage=1001&rft.pages=993-1001&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.115.100503&rft_dat=%3Cpubmed_cross%3E26438212%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-451a3b5e7a47f225268f997a94f48d01b15eaa74cd096ae5ed71fffae021a5383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26438212&rfr_iscdi=true |